![]() |
市場調査レポート
商品コード
1486832
卵円孔開存(PFO)閉鎖機器の世界市場 - 市場考察、競合情勢、市場予測(2030年)Patent Foramen Ovale (PFO) Closure Devices - Market Insights, Competitive Landscape and Market Forecast-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
卵円孔開存(PFO)閉鎖機器の世界市場 - 市場考察、競合情勢、市場予測(2030年) |
出版日: 2024年05月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の卵円孔開存(PFO)閉鎖機器の市場規模は、2024年~2030年の予測期間にCAGRで5.46%の成長が見込まれます。卵円孔開存(PFO)閉鎖機器の需要は主に、老年人口の増加と脳梗塞の罹患率の増加によって強化されています。さらに、世界中で新製品の開発や発売につながる技術の進歩が増大していることも、2024年~2030年の予測期間の市場成長に寄与する大きな要因となっています。
卵円孔開存(PFO)閉鎖機器の市場力学
世界保健機関(WHO)が2022年に発表したデータによると、2030年までに世界の6人に1人が60歳以上の高齢者となります。さらに同資料によると、60歳以上の人口は2020年の10億人から2050年までに14億人に増加します。
国連人口部によると、ドイツの65歳以上の人口は2050年までに41%増の2,400万人になり、総人口の3分の1近くを占めると予測されています。年齢が上がるにつれて、心臓は正常な老化プロセスの一部としてさまざまな構造的/機能的変化を遂げます。これらの変化は心血管系に影響を及ぼし、卵円孔開存(PFO)の持続や発症の一因となる可能性があります。
そのため、老年人口の増加は、卵円孔開存(PFO)閉鎖機器市場の成長にプラスの影響を与える見込みです。
米国脳卒中協会(American Stroke Association)(2021)のデータによると、虚血性脳卒中の約3人に1人(35%)は隠微性脳卒中に分類されます。さらに、原因不明の脳卒中の半分は塞栓性脳卒中です。このように、脳卒中の罹患率が上昇することで、脳卒中の再発を予防する必要性が生じ、結果として卵円孔開存(PFO)閉鎖機器市場の成長を後押しします。
しかし、合併症や機器の長期的な安全性に関連する懸念、卵円孔開存(PFO)閉鎖機器と手術に関連する高いコストなどが、卵円孔開存(PFO)閉鎖機器市場の成長を抑制する可能性があります。
卵円孔開存(PFO)閉鎖機器市場のセグメント分析
卵円孔開存(PFO)閉鎖機器市場の製品タイプセグメントでは、Amplatzer PFOオクルーダーカテゴリが2023年の卵円孔開存(PFO)閉鎖機器市場で大きな収益シェアを獲得すると推定されます。これは、Amplatzer PFOオクルーダー機器が提供するさまざまな利点に起因しています。この機器は、陰窩性脳卒中や再発性片頭痛など、PFOに関連する特定の病状の治療に使用されます。Amplatzer PFOオクルーダーが提供する主な利点の1つは、Amplatzer PFOオクルーダーの挿入が、通常、経カテーテル閉鎖術のような低侵襲手術を用いて行われることです。このアプローチは開心術の必要性を回避し、回復時間の短縮と術後合併症の減少につながります。さらに、この機器はPFOを効果的に閉鎖し、心室間の血栓やその他の物質の通過を防ぐように設計されているため、脳梗塞の潜在的原因である奇異性塞栓症のリスクが減少します。そのため、Amplatzer PFOオクルーダーが提供するさまざまな利点が、このセグメントの成長に寄与すると予測されます。
さらに、このセグメントの需要が拡大するにつれて、市場企業によってさまざまな新製品が市場に投入されています。例えば2022年9月、Abbottは卵円孔開存(PFO)患者の治療に向け、Amplatzer(TM)Talisman(TM)PFO Occlusion Systemを欧州市場で発売しました。
したがって、上記の要因により、Amplatzer PFOオクルーダーは大きな成長を記録し、それによって予測期間に卵円孔開存(PFO)閉鎖機器市場全体の成長を促進すると見込まれます。
北米が卵円孔開存(PFO)閉鎖機器市場全体を独占する見込み
北米は、2023年の卵円孔開存(PFO)閉鎖機器市場で、全地域の中でもっとも高いシェアを占めると予測されます。これは、同地域で脳卒中の罹患率が増加しているためです。さらに、技術の進歩、主要企業のプレゼンス、老年人口の増加に加え、製品の開発、発売、承認の面での高い将来性が、北米の卵円孔開存(PFO)閉鎖機器市場の成長促進要因となっています。
当レポートでは、世界の卵円孔開存(PFO)閉鎖機器市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。
Patent Foramen Ovale Closure Device Market By Product Type (Amplatzer Pfo Occluder, Cardioform Septal Occluder, And Others), End-User (Hospitals And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of cryptogenic stroke and increasing technological advancement leading to new product development
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The demand for Patent Foramen Ovale Closure device is primarily being bolstered by the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development and launches across the globe, is another major factor that is contributing to the growth of the Patent Foramen Ovale Closure market during the forecast period from 2024-2030.
Patent Foramen Ovale Closure Device Market Dynamics:
As per the data provided by the World Health Organization 2022, by the year 2030, 1 in 6 people in the world will be aged 60 years or over. Further, according to the same source the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion and by 2050.
According to the UN Population Division, Germany's population aged 65 and older is projected to grow by 41 percent to 24 million by 2050, accounting for nearly one-third of the total population. As the age increases the heart undergoes various structural and functional changes as a part of the normal aging process. These changes can affect the cardiovascular system, potentially contributing to the persistence or development of a Patent Foramen Ovale.
Therefore, the rise in the geriatric population will positively influence the growth of the Patent Foramen Ovale (PFO) Closure Devices market.
According to the data provided by the American Stroke Association 2021, around one in three which accounts for (35%) ischemic strokes are classified as cryptogenic. Additionally, half of the cryptogenic strokes are embolic strokes, which have an unknown origin. Thus, the rising incidence of cryptogenic strokes will create a need for the prevention of recurrent cryptogenic strokes thus eventually boosting the growth of the Patent Foramen Ovale Closure Device market.
However, the complications and concerns associated with the long-term safety of the device and the high cost associated with the Patent Foreman Ovale Closure Devices and procedures are some of the key constraints that may limit the growth of the Patent Foramen Ovale Closure Device market.
Patent Foramen Ovale Closure Device Market Segment Analysis:
Patent Foramen Ovale Closure Device Market by product type (Amplatzer PFO Occluder, Cardioform Septal Occluder, and Others), End-users (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of the Patent Foramen Ovale Closure Device market, the Amplatzer PFO Occluder category is estimated to amass a significant revenue share in the Patent Foramen Ovale Closure Device Market in 2023. This can be attributed to the various advantages provided by Amplatzer PFO Occluder devices. The device is used for the treatment of certain medical conditions associated with PFO, such as cryptogenic strokes and recurrent migraines. One of the major advantages provided by Amplatzer PFO Occluder devices is that the insertion of the Amplatzer PFO Occluder is typically performed using a minimally invasive procedure, such as transcatheter closure. This approach avoids the need for open-heart surgery, leading to shorter recovery times and reduced postoperative complications. Additionally, the device is designed to effectively close the PFO, preventing the passage of blood clots or other materials between the heart chambers, thus reducing the risk of paradoxical embolism, which is a potential cause of cryptogenic strokes. Therefore, the various advantages provided by the Amplatzer PFO Occluder device is expected to contribute to the growth of the segment.
Furthermore, as the demand for this segment grows, various novel products are launched by market players in the market. For example, in September 2022, Abbott launched its Amplatzer(TM) Talisman(TM) PFO Occlusion System in the European market for the treatment of patients suffering from patent foramen ovale (PFO).
Therefore, owing to the above-mentioned factors, the Amplatzer PFO Occluder is expected to register significant growth, thereby driving the growth of the overall Patent Foramen Ovale Closure Device market during the forecast period.
North America Is Expected To Dominate The Overall Patent Foramen Ovale Closure Device Market:
North America is expected to account for the highest proportion of the Patent Foramen Ovale Closure Device Market in 2023, out of all regions. This is due to the increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, the presence of major players, increasing geriatric population, and a highly potent market in terms of product development, launches, and approvals are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.
According to the data provided by the American College of Cardiology 2019, it was estimated that cryptogenic strokes accounted for 15-40% of all strokes. Additionally, approximately 795,000 individuals suffer from cryptogenic strokes every year in the United States. Thus, the rising incidence of cryptogenic strokes will create a need for the treatment and management of Patent Foramen Ovale, thus resulting in the positive growth of the Patent Foramen Ovale Closure Device Market in the United States, which will eventually propel the Patent Foramen Ovale Closure Device market in North America.
Further, key players present in the region, such as, Abbott, W. L. Gore & Associates, Inc., and Occlutech Holding AG are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.
Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for Patent Foramen Ovale Closure Devices in North America during the forecast period.
Patent Foramen Ovale Closure Device Market Key Players:
Some of the key market players operating in the Patent Foramen Ovale Closure Device market include Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
Recent Developmental Activities In The Patent Foramen Ovale Closure Device Market:
Key Takeaways From The Patent Foramen Ovale Closure Device Market Report Study
Target Audience Who Can Be Benefited From This Patent Foramen Ovale Closure Device Market Report Study
Frequently Asked Questions For The Patent Foramen Ovale Closure Device Market:
A Patent Foramen Ovale Closure Device is a medical device used to close a small hole called a foramen Ovale present between the upper two heart chambers (atria) in patients suffering from patent foramen Ovale.
The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.
The Patent Foramen Ovale Closure Device Market is slated to witness prosperity owing to factors such as the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development across the globe, are some of the other factors resulting in appreciable revenue growth in the Patent Foramen Ovale Closure Device Market during the forecast period (2024-2030).
Some of the key market players operating in the Patent Foramen Ovale Closure Device Market Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.
North America is expected to dominate the overall Patent Foramen Ovale Closure Device Market during the forecast period, 2024 to 2030. This can be ascribed to the presence of developed and sophisticated healthcare infrastructure, rising aging population, and increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, presence of major players, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.